Peginterferon alfa-2b, Ribavirin

Pegasys RBV

180 MCG / 0.5 ML + 200 MG / TAB Solution, TabletCanadaCancelledAuthorised 26 May 2004

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Pegasys Copegus Combination PackUnited States · 180MCG/0.5ML & 1200MG · Hoffmann-La Roche Inc.Same brand
Pegasys Copegus Combination PackUnited States · 180MCG/0.5ML &1000MG · Hoffmann-La Roche Inc.Same brand
Pegasys Copegus Combination PackUnited States · 180MCG/0.5ML & 800MG · Hoffmann-La Roche Inc.Same brand

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Peginterferon alfa-2b, Ribavirin

Pegasys RBV

180 MCG / 0.5 ML + 200 MG / TAB Solution, TabletCanadaCancelledAuthorised 26 May 2004

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Peginterferon alfa-2b, Ribavirin
Strength: 180 MCG / 0.5 ML + 200 MG / TAB
Dosage form: Solution, Tablet
Route: Oral, Subcutaneous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 26 May 2004
Registration: DIN 02253429
Marketing authorisation holder: Hoffmann-LA Roche Limited
ATC code: L03AB61
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION, SCHEDULE D

Cancelled

PegetronPeginterferon alfa-2b + Ribavirin · 80 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 120 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 80 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 150 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 100 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 50 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 120 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled

PegetronPeginterferon alfa-2b + Ribavirin · 100 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For SolutionCanadaCancelled